Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling

Elsa Sánchez‐López; Efrat Flashner-Abramson; Shabnam Shalapour; Zhenyu Zhong; Koji Taniguchi; Alexander Levitzki; Michael Karin

doi:10.1038/onc.2015.326

Back

Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling

Article 2015 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1992

Expression of Growth Hormone Receptor, Insulin-Like Growth Factor 1 (IGF-1) and IGF-1 Receptor mRNA and Proteins in Human Skin

Amir Tavakkol, James T. Elder, Christopher Em Griffiths, Kevin D. Cooper, Harvinder. Talwar, Gary J. Fisher, Karen M. Keane, Susan K. Foltin, John J. Voorhees

Article2005

Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

Qing Xu, Jon Briggs, Sungman Park, Guilian Niu, Marcin Kortylewski, Shumin Zhang, Tanya Gritsko, James Turkson, H. David Kay, Gregg L. Friedman, Jin Cheng, Richard Jove, Hua Yu

Article1998

The Soluble Type 2 Insulin-like Growth Factor (IGF-II) Receptor Reduces Organ Size by IGF-II-mediated and IGF-II-independent Mechanisms

Silvio Zaina, Sarah Squire

Article2024

GAS6 and AXL Promote Insulin Resistance by Rewiring Insulin Signaling and Increasing Insulin Receptor Trafficking to Endosomes

Céline Schott, Amélie Germain, Julie Lacombe, Monica Pata, Denis Faubert, Jonathan Boulais, Peter Carmeliet, Jean‐François Côté, Mathieu Ferron

Preprint2023

GAS6 and AXL promote insulin resistance by rewiring insulin signaling and increasing insulin receptor trafficking to endosomes

Céline Schott, Amélie Germain, Julie Lacombe, Monica Pata, Denis Faubert, Jonathan Boulais, Peter Carmeliet, Jean‐François Côté, Mathieu Ferron